Condition: Multiple Sclerosis · Fatigue · Sponsor: Accelerated Cure Project for Multiple Sclerosis
CAFE-MS will assess the effectiveness of two online programs for fatigue in multiple sclerosis (MS). Although they differ, both of these online programs contain information about MS and fatigue intended to help people with MS understand and manage their fatigue. This large-scale, decentralized clinical trial is projected to enroll 2,000 people with MS. The collaboration between iConquerMS and 5 Veterans Affairs (VA) sites in the MS Centers of Excellence is designed to ensure sufficient representation of people with MS from populations traditionally under-represented in MS clinical trials. The study is a 3-arm, randomized controlled clinical trial with study participation lasting 1 year. Two of the trial arms will include one of two online programs for managing fatigue in MS added to the trial participants' usual MS treatment, and the third arm will include usual MS treatment alone. The online program phase of the trial lasts for 6 months after randomization followed by a final study visit at 12 months. Participants in the usual MS treatment alone arm for the first 6 months will have an opportunity to choose one of the online programs for the final 6 months of the trial.
This description comes directly from the study's public registry record.
Grace Okafor · 781-487-0008 · cafe-ms@iconquerms.org
Always discuss trial participation with your own doctor first.
| Washington VA Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
| Baltimore VA Medical Center | Baltimore, Maryland, United States | Recruiting |
| iConquerMS | Waltham, Massachusetts, United States | Recruiting |
| Portland VA Medical Center | Portland, Oregon, United States | Recruiting |
| Nashville VA Medical Center | Nashville, Tennessee, United States | Recruiting |
| Seattle VA Medical Center | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06441617